Compress development timelines for cell-based therapies. Spend valuable time on your downstream clinical manufacturing steps and final product development and leave the starting and ancillary material to us. With access to multiple donors and a consistent manufacturing process that scales with your clinical progression, you gain a renewed focus on your unique final product development. Reaching clinically-relevant lot sizes in days, not weeks – is now a reality.
CliniControl™ (CC) products are hMSCs and paired bioprocess media manufactured in compliance with cGMPs and supported by U.S. FDA Type II Master Files available for cross reference in your U.S. submissions.